Clinical features and structured clinical evaluation of vasculitis

Area of Science:

• Rheumatology
• Immunology
• Internal Medicine

Background:

• Systemic vasculitides are diverse inflammatory diseases with varied clinical presentations.
• Accurate assessment of disease activity and damage is crucial for guiding therapy and evaluating treatment response.
• Existing assessment tools are well-established for ANCA-associated vasculitis (AAV) but less defined for large-vessel vasculitis.

Purpose of the Study:

• To review current methods for evaluating patients with large-, medium-, and small-vessel vasculitis.
• To highlight the importance of assessing disease activity, damage, prognosis, and quality of life.
• To discuss the evolving role of patient-reported outcomes in vasculitis management.

Main Methods:

• Review of existing literature and clinical trial methodologies in systemic vasculitis.
• Analysis of established assessment tools like the Birmingham Vasculitis Activity Score and Vasculitis Damage Index.
• Discussion of emerging patient-reported outcome measures for vasculitis.

Main Results:

• Established tools effectively assess disease in ANCA-associated vasculitis (AAV).
• Definitive assessment tools for disease activity and progression in large-vessel vasculitis are still needed.
• Patient-reported outcomes are gaining importance for measuring disease impact.

Conclusions:

• Comprehensive assessment of vasculitis patients involves evaluating activity, damage, prognosis, and quality of life.
• Standardized assessment tools are vital for clinical trials and patient management.
• Further development and validation of assessment measures, including patient-reported outcomes, are essential for improving care in all forms of vasculitis.